Key Quantitative Figures

  • IPO Issue Date: September 03, 2026
  • Total Amount Raised: ₹1458.00 lakhs
  • Half Year Ended: September 30, 2026
  • Total Amount Utilized: ₹865.34 lakhs
  • Total Amount Unutilized: ₹592.66 lakhs

Detailed Utilization by Object:

| Objective | Original Allocation (₹ lakhs) | Amount Utilized (₹ lakhs) | Unutilized Amount (₹ lakhs) | Remarks |

| Repayment of borrowings | 250.00 | 0.00 | 250.00 | Unutilized amount temporarily in separate bank account |

| Capital expenditure for plant and machinery | 514.91 | 224.08 | 290.83 | Unutilized amount temporarily in separate bank account |

| Working capital requirements | 300.00 | 300.00 | 0.00 | Fully utilized |

| General corporate purpose | 113.27 | 82.07 | 31.20 | Unutilized amount temporarily in separate bank account |

| Issue-related expenses | 279.82 | 259.19 | 20.64 | Unutilized amount temporarily in separate bank account |

Dates of Action and Approval

  • Board Meeting Date: November 07, 2026
  • Audit Committee Meeting Date: November 07, 2026
  • Certification Date by Auditors: November 07, 2026

Parties Involved

  • Listed Entity: Phychem Technologies Limited
  • Stock Exchange: BSE Limited
  • Statutory Auditors: SANVY & Associates, Chartered Accountants (FRN No. 131547W)
  • Auditor Signatory: CA Sahil Garud, Partner (M. No. 144395)

Financial Impact Disclosure

The company explicitly states there is no deviation or variation in the use of IPO proceeds from the objects stated in the prospectus. All unutilized funds are temporarily held in separate bank accounts awaiting deployment for their designated objects.

Verification and Certification

The statement of no deviation was reviewed by the company's audit committee and taken on record by the board of directors. The statutory auditors, SANVY & Associates, have certified the utilization figures as of September 30, 2026.